Cat: IPD-X38780

Recombinant Human SNRPF Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    SNRPF

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    SMF; Sm-F; SNRP-F

  • Species

    Human

  • Source

    E. coli

  • Tag

    N-His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P62306

  • Expression Region

    Ser2~Glu86

  • Molecular Weight

    15kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

SNRPF (Small Nuclear Ribonucleoprotein Polypeptide F) is a critical component of the splicing machinery in eukaryotic cells, playing a pivotal role in the pre-mRNA splicing process. Research into SNRPF has gained importance due to its involvement in the regulation of gene expression and its potential implications in various diseases, including cancer and neurodegenerative disorders. Mutations and dysregulation of splicing factors like SNRPF can lead to aberrant splicing, contributing to the development and progression of several pathologies. Recent studies have begun to explore the structural and functional aspects of SNRPF, as well as its interactions with other proteins and RNA molecules within the spliceosome complex. Understanding the precise mechanisms by which SNRPF operates and its regulatory networks is essential for elucidating the intricate processes of gene expression. Furthermore, advancements in techniques such as CRISPR/Cas9 and high-throughput sequencing have enabled researchers to investigate SNRPF's roles more comprehensively, potentially leading to novel therapeutic targets for diseases associated with splicing abnormalities. Given its significance, SNRPF is being explored not only for its fundamental biological insights but also for its potential applications in biotechnology and medicine.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US